Zanubrutinib in patients with relapsed/refractory marginal zone lymphoma (MZL): Final analysis of MAGNOLIA (BGB-3111-214)

Linton, KM; Trotman, J; Mckay, P; Ardeshna, K; Iyengar, S; Tedeschi, A; Hu, B; Leitch, S; Jin, J; Sun, M; Sobieraj-Teague, M; Zinzani, PL; Browett, P; Ke, X; Portell, CA; Thieblemont, C; Bijou, F; Walker, P; Hawkes, EA; Ho, SJ; Zhou, KS; Liang, ZY; Xu, JF; Tankersley, C; Delarue, R; Co, M; Opat, S

BRITISH JOURNAL OF HAEMATOLOGY, 2023; 201 (): 12